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Abstract 
Objective: We aimed to evaluate the contribution of the G-protein β3 subunit C825T 
(GNB3-C825T) polymorphism to essential hypertension (EH) in Han Chinese population 
by performing the meta-analysis. Materials/Methods: A meta-analysis was performed in 
12 case-control genetic association studies including 3,020 hypertension patients and 2,790 
controls from MEDLINE (PubMed) and the China National Knowledge Infrastructure 
(CNKI) platforms. The STATA 10.0 software was used in analysis. Results: Overall, there 
was no significant association between the GNB3-C825T polymorphism and EH in neither 
additive [TT vs. CC: OR(95%CI)=1.11(0.74–1.69), P=0.61; TC vs. CC: OR(95%CI)=1.08 
(0.89–1.31), P=0.42], nor dominant [TT+TC vs. CC: OR(95%CI)=1.11 (0.86–1.42), 
P=0.43] and nor recessive [TT vs. TC+CC: OR(95%CI)=1.04 (0.75–1.44), P=0.81] genetic 
models. Although futher subgroup analysis found statistically significant results [T vs. C: 
OR (95%CI) = 1.50 (1.05–2.15), P=0.03] in the southern population, but after exclusion 
one particular study, the significant association was disappeared. No significant result was 
found in the northern population. Conclusions: there was no significant association 
identified between GNB3-C825T polymorphism and EH in Han Chinese population. 
Further larger sample and well-designed studies are needed to assess the genetic 
association particularly in the southern Han Chinese population. 
Keywords: Hypertension, Genetic association study, Systematic review, Han Chinese, 
Meta-analysis. 
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Introduction 
Hypertension is an important worldwide public-health challenge due to the high 
prevalence and is a leading risk factor for mortality (1, 2). An international collaborative 
study reported that 27.2% of the Chinese population aged from 35 to 74 years old have 
hypertension, indicating that hypertension is highly prevalent in Chinese (3). Essential 
hypertension (EH) is one of the most common complex diseases that accounts for 95% of 
all cases of hypertension(4) and is likely to be the consequence of interaction between 
genetic and environmental factors(5). The correlation between high blood pressure 
phenotypes is stronger between parents and children than that between spouses, suggesting 
genetic factors are more crucial than environmental ones(6). To investigate genetic 
mechanisms of hypertension, candidate polymorphisms of the genes involved in the 
pathways of rennin-angiotensin-aldosterone system, autonomic nervous system and 
Na+/H+ exchanger such as G-protein β3 subunit (GNB3)-C825T, angiotensin converting 
enzyme (ACE)-Insertion/Deletion, angiotensinogen (AGT)-M235T and aldosterone 
synthase (CYP11B2)-C344T have been investigated in different ethnic populations(7). 
The GNB3 gene (12p13) (OMIM 139130) encodes the β -3 subunit of heterotrimeric 
G-proteins, composing of three subunits (α, β and γ). (Pls confirm : β -3 subunit of 
heterotrimeric G-proteins, composing of three subunits (α, β and γ). Not logical to 
me?!!!)The β-subunit plays an important role on regulation of the α-subunit and several 
signal transduction receptors and effectors(8). Enhanced GNB3 activation influences 
specific signal transduction pathways, cell proliferation, even immortalized lymphoblast 
and fibroblastsin in patients with EH, together with elevated Na
+
/H
+
 exchange activity(9, 
10). It has been reported that 30–50% of essential hypertensive patients have an increase in 
the activity of Na+/H+ exchanger in their blood cells(11). Therefore, levels and activity of 
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GNB3 could become a candidate marker for predicting the susceptibility to EH. In 1998, 
Siffert et al. first identified a C825T polymorphism at position 825 in exon 10 of the gene 
encoding GNB3 and found GNB3-825T allele was associated with EH(10). Since then, 
many researchers have studied the relationship between GNB3-C825T polymorphism and 
EH in different population with controversial results (12-14). A meta-analysis including 34 
studies observed a significant association between C825T polymorphism and hypertension 
in Caucasians but a non-significant association in Asian populations(14). In China, 
association studies between GNB3-C825T polymorphism and EH have been extensively 
pursued with inconsistent results. Different population structure, latitude distribution, 
ethnic difference and limited statistical power may be the possible contributors to the 
observed inconsistency.  
In this study, we performed a meta-analysis to confirm whether GNB3-C825T 
polymorphism was associated with EH in Han Chinese population and further stratified by 
geographical locations the publications including data published in Chinese to increase 
statistical power and more effectively clarify the role of GNB3 polymorphisms in the 
susceptibility of EH.  
Materials and methods 
Literature search 
We searched MEDLINE (PubMed) and the China National Knowledge Infrastructure 
(CNKI) by employed the following keywords: GNB3-C825T, G-protein beta3, 
polymorphism, hypertension, blood pressure, essential hypertension, China and Chinese. 
The following criteria were established for the study selection: 1) Case-control studies 
concerning the association of GNB3-C825T polymorphism with EH in Chinese 
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populations in China; 2) Having demographic data of subjects, such as Chinese ethnicity 
and geographical locations; and 3) Data on genotype distributions. Hypertension was 
defined as cases if patients had a systolic blood pressure (SBP) ≥ 140 mmHg or a diastolic 
blood pressure (DBP) ≥ 90 mmHg, or they were undergoing antihypertensive treatments. 
Controls were defined as indivdules with a SBP lower than 140 mmHg, or DBP lower than 
90 mmHg, and they were not receiving any antihypertensive therapies. Studies on 
secondary hypertension or with other serious diseases were excluded. In addition, studies 
were excluded from the consideration if: 1) The studies were not designed as case-control 
studies; 2) The source of cases and controls and other essential information was not 
presented; 3) Reviews and duplication of the publications; 4) The control group in studies 
deviated from the Hardy-Weinberg equilibrium; and 5) Subjects of the studies were not 
Han Chinese. 
We separated the selected studies into the Northern studies and the Southern studies 
according to the following criteria. The Huai River-Qinling Mountains line is generally 
regarded as the geographical dividing line between South and North China. If the location 
of the subjects was on the North of the Huai River-Qinling Mountains line, the studies 
were assigned to the Northern studies, otherwise Southern studies. 
Data extraction 
Two investigators extracted standard information from each independent study. From 
each study, the following information was obtained: first author, year of publication, 
geographical location/province, ethnical background of the study population, demographics, 
validity of the genotyping method and numbers of the cases and controls for each genotype 
and allelic frequency of GNB3-C825T polymorphism. To make sure the accuracy of the 
data, extractions were performed by two reviewers independently. 
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Meta analysis 
Statistical analysis was performed with STATA 10.0 software (STATA Corp., 
College Station, Texas, USA; version 10.0). To measure the strength of genetic association 
between GNB3-C825T polymorphism and EH, the odds ratios (OR) and 95% confidence 
interval (95%CI) were calculated. In addition to the investigations using all of the studies, 
comparisons between studies by categorizing subjects into different subgroups according to 
geographical location were also carried out. Heterogeneity among the studies was analyzed 
using the heterogeneity Q statistic test. The inconsistency index I
2
 (ranging from 0 to 100%) 
was also calculated, where higher values of the index indicated the existence of 
heterogeneity(15). If the significant Q statistic (P<0.1) indicated the existing of 
heterogeneity across studies, the DerSimonian and Laird method in the random effects 
model was used for meta-analysis. Otherwise, the Mantel-Haenszel method in the fixed 
effect model was used. Sensitivity analyses were performed by sequentially omitting one 
study each time to assess each potential influence of the individual study on the pooled 
estimate. We also performed Egger’s test to examine publication bias. A goodness-of-fit χ2 
test was used to check whether the frequencies of genotypes deviation from the 
Hardy-Weinberg Equilibrium (HWE) 
(http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl). P<0.05 was considered 
statistically significant. 
Results 
Characteristics of studies 
The initial search with the keywords identified a total of 27 studies. Of the 27 studies, 
three studies were excluded because the study population was not the Han Chinese 
7 
 
population (13, 16, 17) and two articles were excluded since they were pedigree-based 
research(18, 19). Among the other excluded studies, two studies were duplicate 
publications (20, 21) and three studies were reviews(22-24). Furthermore, four studies were 
excluded due to the deviation from the Hardy-Weinberg equilibrium in the control groups 
(25-28). Thus, 12 case-control studies including a total of 5,810 individuals (3,020 
unrelated hypertensive patients and 2,790 normotensive controls) were included in the 
present investigation. Seven case and control studies were selected from hospital (12, 30, 
33-35, 37, 38), while four community-based cases and controls were used (31, 32, 36, 39). 
In one study, samples were selected from both hospital and community (29). The WHO 
criteria for hypertension diagnosis were used in all included studies. The method of 
genotyping test was PCR-RFLP in all included studies.  
The characteristics of all included studies are shown in Table 1. Among the eligible 
studies, three of which investigated Southern Han Chinese populations including Shenzhen 
city (Guangdong), Henan and Chongqing City (Sichuan) provinces (29-31). Other subjects 
came from Northern Han Chinese populations including Beijing City, Heilongjiang, Jilin, 
Liaoning, Shandong and Shanxi provinces(12, 32-39). According to the data of all studies, 
the frequency of GNB3-825T allele was 47.3% for hypertension and 48.2% for 
normotensive control. In the Northern population, the frequency of the GNB3-825T allele 
was 48.7% (47.5% for cases and 50.0% for controls), while the GNB3-825T allele 
frequency was 40.6% (45.5% for cases and 36.1% for controls) in Southern studies. There 
was a significant difference between the Southern and the Northern populations (χ2=31.017, 
P<0.001). After exclusion the study from Chongqing study, the significant difference of T 
allele frequency was not found between northern and southern populations (45.2% for 
southern population and 48.7% for northern population, χ2 = 3.762, P = 0.052). 
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Meta analysis in all investigated studies 
In the meta-analysis of all involved studies, there was no significant association 
between GNB3-C825T polymorphism and EH in the Chinese Han population (Table 2). 
The Q test showed heterogeneity in the 12 studies. We therefore used the random effects 
model to calculate the combined effects in three genetic models. The OR (95% CI) were 
TT vs. CC: 1.11 (0.74–1.69), P=0.61; TC vs. CC: 1.08 (0.89–1.31), P=0.42 in additive 
model; similarly, no significant association was identified neither in the dominant model 
(OR=1.11; 95% CI: 0.86–1.42, P=0.43) nor in the recessive model (OR=1.04; 95% CI: 
0.75–1.44, P=0.81). Heterogeneity between studies was identified in the all comparisons (P 
for heterogeneity Q test < 0.1). Furthermore, the I
2
 statistics suggested an existence of 
extreme heterogeneity for all comparisons in all studies. 
Subgroup analysis 
Heterogeneity was found between each of the studies (Table 2). Therefore, a 
sub-group analysis of the studies by geography grouping of Northern and Southern China 
was suggested. With no further evidence of heterogeneity in each sub-group, we used the 
fixed effects model to evaluate the pooled OR of three Southern population studies (Figure 
1). We observed that the presence of GNB3-825T allele was significantly associated with 
higher risk of EH than that of GNB3-825C allele carriers (T vs. C: OR=1.50, 95% CI: 
1.05–2.14, P=0.026) in Southern Han Chinese population. However, there was no 
statistically significant association in Northern Han Chinese population (T vs. C: OR=0.98, 
95% CI: 0.79–1.21, P=0.829). The same results were observed in all three genetic models 
(detailed data was not shown). Between-study heterogeneity was found in the Northern 
studies (P for heterogeneity Q test < 0.001), but not in the Southern studies (P for 
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heterogeneity Q test=0.101). 
Sensitivity analysis 
To further strengthen the confidence for the results, we conducted a sensitivity 
analysis and the result showed that there was little modification of the estimates after 
exclusion of an individual study, with pooled ORs ranging from 0.89 to 1.07. Similarly, 
exclusion of individual Northern studies did not modify the estimates much, with pooled 
ORs ranging from 0.91 to 1.05. However, among the South studies, Chongqing study from 
Sichuan province influenced the combined effects with distinct modification. Since the T 
allele frequency of Chongqing province was 23.2% in controls, which was significantly 
lower than other studies as we discussed above (Table 1). After exclusion of this 
Chongqing study, no significant association was found between GNB3-C825T 
polymorphism and EH in the Southern studies (OR=1.26, 95%CI: 0.94-1.68, P = 0.123). 
There was no difference in the Northern data analyzed by either fixed effect model or 
random effect model. The results from fixed effect model was OR (95%): 0.92 (0.85-1.00), 
and from random effect model was OR (95%): 0.98 (0.79-1.21), respectively. 
Publication bias 
Publication bias, i.e., the manuscripts can be accepted and published easier if they 
contain positive results. This is an important consideration in estimating the reliability of 
meta-analysis. In this study, there was no publication bias for GNB3-C825T 
polymorphism by Egger’s test (t=0.49, P = 0.631). However, the funnel plot showed the 
asymmetrical distribution of the studies (Figure 2). 
Discussion 
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GNB3-C825T polymorphism was demonstrated to result in the lack of 41 amino acids 
in β3 subunit of trimeric G-proteins and was shown to be associated with hypertension (10). 
This polymorphism has also been associated with enhanced G-protein signaling(10, 40, 41), 
presumably through abnormal stability or functional interactions of the shortened 
G-proteins as the polymorphism does not affect GNB3 mRNA levels(40). A case-control 
study found that GNB3-C825T polymorphism influenced plasma sodium and potassium 
concentrations in essential hypertension patients, evidenced by an increased activity of the 
Na+/H+ exchanger(42). Thus, GNB3-C825T polymorphisms could be a valuable marker 
for predicting the susceptibility to hypertension and/or salt sensitivity (9, 10). 
In recent years, many studies have reported a correlation between GNB3-C825T and 
EH in Caucasian, African, South American and Asian populations, respectively (43, 44). 
However, there were also discrepant conclusions in the other investigations (45, 46). Bogos 
et al.(14) carried out a meta-analysis of total 34 studies with 14,094 hypertensive patients 
and 17,760 controls from Caucasian, African and Asian populations, and confirmed that 
GNB3-825T allele was correlated with EH (TT vs. CC + CT: OR=1.08; 95% CI: 1.01-1.15, 
P<0.001 and TT + CT vs. CC: OR=1.17; 95% CI: 1.06-1.29, P<0.001). But further 
subgroup analysis failed to identify significant associations from studies in Asian 
populations. Our meta-analysis showed that the GNB3-C825T polymorphism was not 
associated with EH in Han Chinese populations, which is in agreement with the result of 
the above multiethnic population meta-analysis(14). When stratifying for the geographical 
location, we observed that GNB3-825T allele (OR = 1.50, 95% CI: 1.05-2.15, P=0.026) 
was a risk factor for EH in Southern Han Chinese populations. However, only three 
investigations on the Southern Han Chinese populations were eligible and selected for the 
meta-analysis, and thus less EH patients and normotensive individuals were in this study. 
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False-positive result, therefore, is not negligible. Furthermore, in the sensitivity analysis, 
we found that the allelic frequency of GNB3-C825T from the study of Chongqing study 
from Sichuan province significantly influenced the combined effects in studies conducted 
in Southern China. After excluding of this study, the significant association in South 
studies disappeared. Therefore, it should be very cautious to draw a conclusion on a 
significant association between GNB3-C825T polymorphism and EH in Southern Han 
Chinese population.  
It should be taken into consideration that the GNB3-825T allele was thought to be a 
‘thrifty genotype’, similar with AGT-M235T polymorphism, due to the high frequency in 
original ethnicities and significant correlation with obesity(47). On the other hand, 
GNB3-825T, AGT-235T and cytochrome P450 3A5 (CYP3A5)-*1 alleles contribute to the 
susceptibility to salt sensitivity(48), suggesting that these polymorphisms may present the 
same distributions under the same selective pressure. It has been reported that the 
frequencies of AGT-235M and CYP3A5-*3 allele increase with distance from the equator 
(r=0.712, P < 0.001 and r=0.612, P < 0.001) (49), meanwhile indicating that GNB3-825T 
allele decreases with the distance from the equator. In addition, an increase in latitude 
associated with lower frequency of GNB3-825T allele was confirmed by the Human 
Genome Diversity Project (HGDP) (50). In the current study, we calculated the frequency 
of GNB3-825T allele of all the studies included in the meta-analysis, and further analyzed 
the association of the frequency with latitude of geographical regions. We failed to observe 
the correlation between GNB3-825T allele and latitude (r=0.469, P=0.106), and similar 
result was obtained after removing the Chongqing study (r=0.322, P=0.307). It is worth 
noting that less number of the studies from Southern population may reduce the statistical 
analysis power and lead to failure of detecting the association between the frequency of 
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GNB3-825T allele and latitude in Han Chinese population. Although we were not able to 
identify the problems in the study design and SNP genotyping methods, the rather low 
frequency of GNB3-825T allele in the Chongqing is attributable to the sample selection 
bias or lack of quality control for the genotyping analysis. More studies from South of 
China are needed to re-estimate the frequency. 
The negative result in the Chinese Han population might be caused by interethnic 
differences. Siffert et al. (51) analyzed the distribution frequencies of GNB3-C825T from a 
German cohort, Chinese and African populations, and founded that T allele frequencies 
differed significantly between different ethnic groups and were the lowest in Germans 
(31.9%), intermediate in Chinese (47.7%) and the highest in Africans (81.4 to 84.1%). In 
our study, the average frequency of T allele, similar to their reports, was 47.7% in Han 
Chinese population. In addition, two studies in Japanese populations reported the 
frequencies of GNB3-825T allele 49.2% and 50.1%, respectively, and the study did not 
observe any significant associations between GNB3-C825T polymorphism and EH either 
(45, 52). The different genotypic frequencies of GNB3-825T allele might influence the 
phenotypes related to hypertension, such as salt sensitivity, in different ethnic population 
(53), which may contribute to different correlations between Chinese Han and other 
populations. Therefore, the genetic background and heterogeneity of the study populations 
might influence the results of association studies between genetic polymorphisms and EH. 
Several potential limitations in this study are worth noting. Firstly, although the 
Egger’s test is not significant, an asymmetric funnel plot suggests the existence of bias. 
Except for publication bias, possible reasons for asymmetry in funnel plots in this 
meta-analysis may be genotype testing, poor study design, heterogeneity and chance 
findings (54). Secondly, the number of investigations is not large enough to confirm or 
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reject a genetic association reliably, especially given there are only three eligible studies 
with the Southern populations. Therefore, the effect of possible false-negative findings of 
the individual studies due to low statistical power could affect the overall results of this 
meta-analysis. Thirdly, as a research method, meta-analysis has some limitations, e.g. 
meta-analysis cannot neither eliminate the between-study heterogeneity nor improve the 
quality of original studies. Therefore, well-designed large-scale studies are needed for 
providing sufficient statistical power to detect the associations. Based on the current 
meta-analysis, some limitations of the eligibility of the studies should also be considered. 
These limitations are common in genetic epidemiology studies and are propagated in a 
meta-analysis. Among the 12 eligible studies, only eight studies’ controls were matched for 
age and gender to the cases. The selection bias of controls from inpatient, outpatient or 
random samples was another potential source of variation in different studies. Furthermore, 
there were not enough information on the various potential confounders in the some of 
these original publications, such as age, gender, BMI, SBP and DBP. 
Conclusions 
Our results of the meta-analysis suggested that GNB3-825T allele is not associated 
with the increased risk of EH in Chinese Han population. Larger and well-designed studies 
including different regional Han Chinese populations should be considered in future 
studies. 
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